BLISSGVSBSEBLISS GVS PHARMA LTD· PharmaceuticalsMediumNeutral
Announced Thu, 15 Oct, 2026 · 18:22 IST

Postal ballot to appoint 3 new directors nominated by new promoter Anupam Rasayan

BLISSGVS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+0.4%Reaction day
₹652.00
prior close
₹651.00
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+0.7%-0.3% vs market
Pharmaceuticals peers, median of 173sector+0.0%+0.4% vs sector

On the reaction day the stock moved 0.3 pts less than Nifty Microcap 250 and 0.4 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+0.5
10m
-0.1
15m
-0.4
30m
-1.4
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+0.4+0.7-0.3+0.0+0.4
Next day
-4.9-1.0-3.9-1.2-3.7
2d
-4.5-3.6-0.9-2.8-1.6
3d
-1.4-4.5+3.1-3.9+2.5
4d
-4.8-6.8+1.9-5.1+0.3
5d
-3.9-6.4+2.5-3.9+0.0
1w
—————
15d
—————
1m
—————
2m
—————
3m
—————
UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 173Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Bliss GVS Pharma has sent a postal ballot notice seeking shareholder approval to appoint 3 Non-Executive Non-Independent Directors: Mr. Hetul Krishnakant Mehta, Mr. Amar Dilip Shah, and Mr. Pramod Badrinarayan Kasat. They were nominated by Anupam Rasayan India Limited and Mates Visa Consultancy Private Limited, who became new promoters after a Share Purchase Agreement dated May 23, 2026, and completion of an open offer. E-voting runs from Oct 16 to Nov 14, 2026, with results by Nov 17, 2026.

Likely market impact

New promoters Anupam Rasayan and PAC are reconstituting the board with their own nominees, marking a change of control at the company.